Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles

Published:2012-07 Issue:5 Volume:8 Page:692-701
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Jalali Seyed Amir,Sankian Mojtaba,Tavakkol-Afshari Jalil,Jaafari Mahmoud Reza

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference50 articles.

1. Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu;Riemer;J Immunol,2004

2. Peptide vaccines against cancer;Berzofsky;Cancer Treat Res,2005

3. Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04;Carmichael;Cancer,2010

4. The impact of HER2/neu expression level on response to the E75 vaccine: United States Military Cancer Institute Clinical Trials Group Study I-01 and I-02;Benavides;Clin Cancer Res,2009

5. Tumor-specific shared antigenic peptides recognized by human T cells;Van Der Bruggen;Immunol Rev,2002

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIM kinase inhibitor AZD1208 in conjunction with Th1 cytokines potentiate death of breast cancer cells in vitro while also maximizing suppression of tumor growth in vivo when combined with immunotherapy;Cellular Immunology;2024-03

2. Cancer Vaccines Designed Based the Nanoparticle and Tumor Cells for the Treatment of Tumors: A Perspective;IET Nanobiotechnology;2024-02-24

3. Peptide and protein in vaccine delivery;Peptide and Protein Drug Delivery Using Polysaccharides;2024

4. Nano-adjuvants and immune agonists promote antitumor immunity of peptide amphiphiles;Acta Biomaterialia;2023-04

5. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen;International Immunopharmacology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3